The European Eye Epidemiology spectral-domain optical coherence tomography classification of macular diseases for epidemiological studies.

The European Eye Epidemiology spectral-domain optical coherence tomography classification of macular diseases for epidemiological studies.

Gattoussi S, Buitendijk GHS, Peto T, Leung I, Schmitz-Valckenberg S, Oishi A, Wolf S, Deák G, Delcourt C, Klaver CCW, Korobelnik JF; European Eye Epidemiology (E3) consortium.

Acta Ophthalmol. 2019 Jun;97(4):364-371. doi: 10.1111/aos.13883. Epub 2018 Sep 22.

2019

Electrochemical Immunosensor for TNFα-Mediated Inflammatory Disease Screening.

Electrochemical Immunosensor for TNFα-Mediated Inflammatory Disease Screening.

Cruz A, Queirós R, Abreu CM, Barata C, Fernandes R, Silva R, Ambrósio AF, Soares-Dos-Reis R, Guimarães J,Sá MJ, Relvas JB, Freitas PP, Mendes P Cruz A, Queirós R, Abreu CM, Barata C, Fernandes R, Silva R, Ambrósio AF, Soares-Dos-Reis R, Guimarães J,Sá MJ, Relvas JB, Freitas PP, Mendes Pinto I.

ACS Chem Neurosci. 2019 Jun 19;10(6):2676-2682. doi: 10.1021/acschemneuro.9b00036. Epub 2019 Apr 18. into I.Electrochemical Immunosensor for TNFα-Mediated Inflammatory Disease Screening. ACS Chem Neurosci. 2019 Jun 19;10(6):2676-2682. doi: 10.1021/acschemneuro.9b00036. Epub 2019 Apr 18.

2019

Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results.

Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results.

Busch C, Fraser-Bell S, Iglicki M, Lupidi M, Couturier A, Chaikitmongkol V, Giancipoli E, Rodríguez-Valdés PJ, Gabrielle PH, Laíns I, Santos AR, Cebeci Z, Amphornphruet A, Degenhardt V, Unterlauft JD, Cagini C, Mané-Tauty V, D’Amico Ricci G, Hindi I, Agrawal K, Chhablani J, Loewenstein A, Zur D, Rehak M; International Retina Group.

Acta Diabetol. 2019 Dec;56(12):1341-1350. doi: 10.1007/s00592-019-01416-4. Epub 2019 Sep 21.

2019

Serum pro-inflammatory factors as predictors of persistent diabetic macular oedema with limited anatomic response to anti-VEGF: association with intravitreal injection treatment profiles in real-world setting.

Serum pro-inflammatory factors as predictors of persistent diabetic macular oedema with limited anatomic response to anti-VEGF: association with intravitreal injection treatment profiles in real-world setting.

Brito P, Costa J, Gomes N, Costa S, Correia-Pinto J, Silva R.

Acta Ophthalmol. 2019 Nov 19. doi: 10.1111/aos.14308. [Epub ahead of print]